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Abstract: A series of new 3-Aryl-4-(4-methoxyphenyl)-1-phenyl-4,5-dihydro-1H-pyrazole-5-carbonitriles (1)
were screened in vitro for their antibacterial and antifungal activities against four different organisms. The
minimal inhibitory concentration (MIC’s) was determined against each organism. The compounds were tested
for their antioxidant activity and reducing power ability. The effect of substitution on the activity, and the
possible structure activity relationship mechanism of the compounds for their antioxidant activity are presented.
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INTRODUCTION
The pyrazoles constitutes an interesting class of
organic compounds with diverse chemical and
biological application. They are known to possess
variety of biological activities such as analgesic,
anti-inflammatory, protein kinase C inhibitor1. A
series of pyrazoles have known to exhibit significant
fungicidal activities against Corynespora
cassiicola2, antitubercular, antimicrobial activity3,
anticancer4, analgesic, anti-inflammatory5 and
antibacterial activity6. Many pyrazole derivatives
possess remarkable antiepileptic and antimicrobial7,
potent and selective inhibitors of tissue-nonspecific
alkaline phosphatase8, antiamoebic9, and
antiandrogenic activities10.
The pyrazole nucleus is a ubiquitous feature
of pharmacological interest and has been proven to
be a fertile source of medicinal agents. Some of
these compounds have also exhibited antidiabetic11,
anaesthetic12 properties. N-phenyl pyrazoles
synthesized from 4-(2-bromoacetyl)-5-methyl-1-
phenylcarbamoyl-1H-pyrazole as versatile synthons
exhibited a potent antimicrobial activity13. Rai et
al14-15 reported the synthesis of pyrazoles,
pyrazolones, bis-heterocycles bearing pyrazoline and
imidazole moieties and their antimicrobial and
antioxidant activity. This paper describes in vitro
screening results of the title compounds for their
antimicrobial activity, minimum inhibitory
concentrations, antioxidant activity and reducing
power.
EXPERIMENTAL
In view of the enormous biological potency
associated with pyrazole derivatives, a series of new
3-Aryl-4-(4-methoxyphenyl)-1-phenyl-4,5-dihydro-
1H-pyrazole-5-carbonitriles (1a-h) were selected in
the present work for the study of their biological
activities. The antimicrobial activity of the
synthesized compounds (1a-h) was done by paper
disc diffusion method16.
K.Ajay Kumar et al /Int.J.PharmTech Res.2013,5(1) 265
ANTIBACTERIAL ACTIVITY
The representative compounds (1a-h) were tested at
a concentration (50 µg/mL) in methanol on the
nutrient agar media against Gram-negative bacteria
species Escherichia coli, Salmonella typhimurium,
Gram-positive bacteria species Bacillus substilis,
and Staphylococus aureus. The antibiotic
streptomycin was used as standard drug against
bacteria. The paper discs inoculated with bacteria
were incubated for 24 hrs at 37⁰C. After incubation,
the zone of inhibition produced by the test
compounds was measured. The screening tests were
performed in triplicate and the results were taken as
a mean of three determinations.
Minimum inhibitory concentrations
(MICs) were determined by broth dilution technique.
The nutrient broth, which contain logarithmic
serially two-fold diluted amount of test compound
and controls were inoculated with approximately 5 x
105 c.f.u of actively dividing bacteria cells. The
cultures were incubated for 24 hrs at 37⁰C and the
growth was monitored visually and
spectrophotometrically. The lowest concentration
required to arrest the growth of bacteria was
regarded as minimum inhibitory concentration
(MIC). All the experiments were carried out in
triplicate and the results were taken as a mean of
three determinations.
ANTIFUNGAL ACTIVITY
The test compounds (1a-h) were evaluated for their
antifungal activity against the fungi species
Aspergillus niger, Aspergillus flavus, C. albicans,
and Fusarium oxysporium strains at a concentration
of 25 µg/mL in DMF in the potato dextrose agar
media. The antibiotic Griseofulvin was used as
standard drug against fungi. The paper discs
inoculated with fungi were incubated for 72 hrs at
37⁰C. After incubation, the zone of inhibition
produced by the test compounds was measured in
mm. The screening tests were performed in triplicate
and the results were taken as a mean of three
determinations.
Minimum inhibitory concentrations
(MICs) were determined by broth dilution technique.
The cultures were incubated for 72 hrs at 37⁰C and
the growth was monitored visually and
spectrophotometrically. All the experiments were
carried out in triplicate and the results were taken as
a mean of three determinations.
ANTIOXIDANT ACTIVITY
The antioxidant activity of the compounds
(1a-h) was assessed by evaluating their DPPH
radical scavenging ability17. Butylated hydroxyl
toluene (BHT) was used as an antioxidant.. Samples
dissolved in methanol (0-50 µg/mL for samples 1a-
h; 0-5 µg/mL for BHT) in 200 µL aliquot was mixed
with 100 mM tris-HCl buffer (800 µL, pH 7.4) and
then added 1 mL of 500 µM DPPH in ethanol (final
concentration of 250 µM). The mixture was shaken
vigorously and left to stand for 20 min at room
temperature in dark. The absorbance of the resulting
solution was measured spectrophotometrically at
517 nm. All the experiments were carried out in
triplicates at different concentrations (10-50 µg/mL)
and the results are expressed as mean of the three
determinations.
REDUCING POWER
The reducing power ability of samples 1a-h was
determined by a known method18. The samples 1a-h
(0-50 µg/mL) was mixed with an equal volume of
0.2 M phosphate buffer, pH 6.6 and 1% potassium
ferricyanide. The mixture was incubated at 50oC for
20 min. Then an equal volume of 10%
trichloroacetic acid was added to the mixture and
then centrifuged at 5000 rpm for 10 min. the upper
layer of solution was mixed with distilled water and
0.1% ferric chloride at a ratio of 1:1:2 and the
absorbance were measured at 700 nm. Increased
absorbance of the reaction mixture indicated
increased reducing power. All the experiments were
carried out in triplicates and the results are expressed
as mean of three determinations.
RESULTS AND DISCUSSION
The results of antibacterial activity of the test
compounds shows that; the compounds 1a-c showed
remarkable activity against E.coli, S.typhimurium
and B. substilis and moderate against S. aureus,
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which is attributed to the presence of fluoro, chloro,
bromo substituents at C3-substituted benzene ring.
The compounds 1d and 1h showed lesser activity
against all the bacterium, this might be expected due
to the presence of strong electron withdrawing -CN
substituent on the aromatic ring and the 2-furanoyl
substituent to the pyrazole nucleus respectively. The
compounds 1e-g showed higher activity against
E.coli and S.typhimurium, moderate against B.
substilis and weak against S. aureus, this was
expected to the presence of electron donating –
OCH3 groups on the aromatic ring. It was interesting
to notice that, with increase in the number of –OCH3
groups on the ring; enhanced their activity from 1e
to 1g. The results that the presence of electron
donating groups such as –OCH3 on the substituted
benzene ring and fluoro, chloro and bromo
substituents C5-substituted benzene ring were better
antibacterial agents (Fig 1). The results indicate that
the compounds 1a-c may be used as control
measures against different bacteria. The results of
MIC’s determined reveal that some of these test
compounds can act as good antibacterial agents at
very lower concentrations (Fig 2).
The results of antimicrobial activity of the
compounds show that all possess promising
antifungal activity against A. niger and A. flavus;
moderate or weak activity against C. albicans and F.
oxysporium The compound 1d exhibited very weak
inhibition against all the organisms tested, it might
be expected due to the presence of electron with
drawing –CN group on the aromatic ring. From the
results of the study, it was observed that the
presence of halogen substituents and electron
donating substituents enhances the activity against
many fungi organisms (Fig 3). The results of MIC’s
determined reveal that some of these test compounds
can act as good antibacterial agents at very lower
concentrations (Fig 4).
The free radical scavenging ability of
samples 1a-h was evaluated by DPPH scavenging
model system using the equation-1. All the
synthesized compounds showed promising free
radical scavenging ability, but of lesser activity
when compared with the standard antioxidant. At the
initial concentrations of (10-20 µg/mL), not much
significant variations in the free radical scavenging
ability of samples 1a-h was observed. However,
when the concentration was increased (30-50
µg/mL) all showed a promising radical scavenging
ability. The compounds 1a-d showed radical
scavenging ability up to 60%; the compounds 1e,f,h
showed up to 45% and the compound 1g showed
32% with reference to the standard antioxidant.
From the results, it was observed that, the presence
of strong electron withdrawing substituents
enhanced the antioxidant property of the test
compounds; the electron donating substituents
retards the antioxidant property of the test
compounds (Table 1). The EC50 values in µg/mL
were determined for the antioxidant activity of the
test samples measured at different concentrations
(Fig 5). The experimental results indicate the
potential electron donating ability of synthesized
compounds.
The samples 1a-h was evaluated for their reducing
power ability to reduce ferric chloride and potassium
ferricyanide complex. It was observed that at the
initial concentrations of (10-20 µg/mL), there was
no significant variations in the activity. However,
when the concentration was increased (30-50
µg/mL), all showed remarkable reducing power. The
compounds 1a-d showed higher reducing power and
1e-h showed moderate reducing power. The
increased absorbance at 700 nm indicated the
presence of reducing power of the synthesized
compounds (Fig 6).
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Table 1: Percentage of Radical Scavenging activity of samples 1a-h relative to
the standard antioxidant BHT.
Concentration (μg/mL)Samples 10 20 30 40 50
1a 10.46 13.30 28.81 38.52 58.73
1b 13.12 16.36 29.42 40.23 59.92
1c 11.22 14.96 27.61 36.96 52.67
1d 14.76 16.23 31.90 45.66 60.17
1e 11.16 13.22 26.90 34.61 42.18
1f 09.32 11.22 22.26 30.22 38.96
1g 8.12 10.36 19.80 26.75 31.80
1h 12.12 14.36 28.80 35.75 44.80
*Values are expressed as mean of the three determinations (n=3)
Structure-Activity relationship of antioxidant
activity
2,2-Diphenyl-1-1-picrylhydrazyl is a stable organic
nitrogen radical that acts as a scavenger for other
radicals. It was characterized by a typical deep
purple color and has a maximum absorbance in the
range of 515-520 nm. DPPH radical scavenging test
evaluates in vitro antioxidant capacity. In presence
of hydrogen/electron donor or free radical
scavenging antioxidants, the absorption intensity is
decreased and the radical solution is decolorized to
pale yellow color according to the number of
electrons captured (Equation 2).
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The relatively unstable non-aromatic 3-Aryl-4-(4-
methoxyphenyl)-1-phenyl-4,5-dihydro-1H-pyrazole-
5-carbonitriles (1) on catalytic dehydrogenation,
produces a stable aromatic 3-Aryl-4-(4-
methoxyphenyl)-1-phenyl-pyrazole-5-carbonitriles
(2) (Equation 3).
The instability of the 3-Aryl-4-(4-methoxyphenyl)-
1-phenyl-4,5-dihydro-1H-pyrazole-5-carbonitriles
(1) was expected to be the driving force for their
antioxidant activity. From the experimental results,
the stiochiometry of the reaction was found to be 1:2
for test compounds: DPPH free radical. This
suggests that each molecule (1) has a tendency to
donate two hydrogen atom and two electrons to the
acceptor molecules. In the presence of hydrogen
donor organic compound (1) the DPPH free radical
abstract the hydrogen atom bonded to C5-atom along
with one of its bonded electron to give organic free
radical and it becomes reduced (DPPH-H). The
second molecule of DPPH free radical abstracts the
hydrogen atom of C4-atom with one of its bonded
electron to give organic diradical and it becomes
reduced (DPPH-H). The organic diradical expected
to undergo intramolecular coupling to form stable
organic compound (2) (Equation 4).
On the basis of this speculation, the C4 and/or C5
positions of the pyrazole ring may be the active site
responsible for antioxidant activity of the screened
pyrazole derivatives.
CONCLUSION
The potency in their biological activity of the new
compounds validates the significance of this study.
The study revealed that the most of the compounds
tested showed moderate to good activity. However,
the effect of compounds on the host cell and their
mode of action remain to be studied.
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